| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | PROVIDENCE HEALTH & SERVICES-WASHINGTON | 101 W 8TH AVE | SPOKANE | WA | 99204-2307 | SPOKANE | USA | U3REP220680 | Regional Emerging Special Pathogens Treatment Center Cooperative Agreement for Region 10 | 01 | 2 | ASPR | 4/3/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,615,384 ) |
| | 2023 | 2023 | PROVIDENCE HEALTH & SERVICES-WASHINGTON | 101 W 8th Ave | Spokane | WA | 99204-2307 | SPOKANE | USA | U3REP220680 | Regional Emerging Special Pathogens Treatment Center Cooperative Agreement for Region 10 | 00 | 2 | ASPR | 9/22/2023 | $1,615,384 |
| | 2023 | 2022 | PROVIDENCE HEALTH & SERVICES-WASHINGTON | 101 W 8th Ave | Spokane | WA | 99204-2307 | SPOKANE | USA | U3REP220680 | Regional Emerging Special Pathogens Treatment Center Cooperative Agreement for Region 10 | 02 | 1 | ASPR | 11/7/2022 | $1,200,000 |
| | 2023 | 2022 | PROVIDENCE HEALTH & SERVICES-WASHINGTON | 101 W 8th Ave | Spokane | WA | 99204-2307 | SPOKANE | USA | U3REP220680 | Regional Emerging Special Pathogens Treatment Center Cooperative Agreement for Region 10 | 01 | 1 | ASPR | 10/14/2022 | -$1,200,000 |
|
| Issue Date FY: 2022 ( Subtotal = $1,200,000 ) |
| | 2022 | 2022 | PROVIDENCE HEALTH & SERVICES-WASHINGTON | 101 W 8th Ave | Spokane | WA | 99204-2307 | SPOKANE | USA | U3REP220680 | Regional Emerging Special Pathogens Treatment Center Cooperative Agreement for Region 10 | 00 | 1 | ASPR | 9/29/2022 | $1,200,000 |
|
| Issue Date FY: 2012 ( Subtotal = $307,940 ) |
| | 2012 | 2012 | PROVIDENCE HEALTH & SERVICES- WASHINGTON | POST OFFICE BOX 11038 | SEATTLE | WA | 98011 | | USA | R34DK094016 | MEDICATION INTERVENTION IN TRANSITIONAL CARE TO OPTIMIZE CKD OUTCOMES & COSTS | 000 | 2 | NIH | 9/18/2012 | $307,940 |
|
| Issue Date FY: 2011 ( Subtotal = $313,415 ) |
| | 2011 | 2011 | PROVIDENCE HEALTH & SERVICES- WASHINGTON | POST OFFICE BOX 11038 | SEATTLE | WA | 98011 | | USA | R34DK094016 | MEDICATION INTERVENTION IN TRANSITIONAL CARE TO OPTIMIZE CKD OUTCOMES & COSTS | 000 | 1 | NIH | 9/26/2011 | $313,415 |
|
|
